中审华会所收警示函！

Core Viewpoint - The Tianjin Regulatory Bureau issued a warning letter to Zhongshunhua Accounting Firm and its auditors Zhang Xuebing and Li Yuan due to deficiencies in the audit process of Tianyao Pharmaceutical Co., Ltd.'s 2024 annual report, highlighting inadequate execution of control testing procedures and insufficient audit procedures for external projects [1][2][3][4]. Group 1: Audit Deficiencies - The audit team failed to execute control testing procedures effectively for Tianyao Pharmaceutical's research and development projects, lacking specificity and effectiveness, which resulted in insufficient and inappropriate audit evidence to identify contract management deficiencies [2]. - The audit procedures for the management of external projects were inadequately performed, as the audit team did not maintain necessary professional skepticism regarding the lack of progress in certain external projects in 2023 and 2024, failing to identify management deficiencies [3]. Group 2: Regulatory Violations - The actions of the audit team were found to be non-compliant with the Chinese CPA Auditing Standards, specifically Articles 8 and 9 of the Standard No. 1231 and Article 10 of the Standard No. 1301, as well as violations of the relevant provisions of the Management Measures for Information Disclosure of Listed Companies [3]. - Zhang Xuebing and Li Yuan, as the signing auditors for Tianyao Pharmaceutical's 2024 annual audit report, bear primary responsibility for these violations, contravening Article 45 of the Management Measures for Information Disclosure of Listed Companies [3]. Group 3: Consequences and Remedial Actions - The Tianjin Regulatory Bureau decided to issue a warning letter to Zhongshunhua and the auditors, requiring them to learn from the experience, strictly adhere to relevant laws and regulations, and improve audit quality [4]. - Zhongshunhua and the auditors are required to submit a written report on their rectification measures within 30 days of receiving the decision [4].